SUBSCRIBE
SUBSCRIBE

Australia

Who Will Trump Go After Next?
Biotech Bay
BioPharm Executive: Who Will Trump Go After Next?
April 18, 2017
 · 
4 min read
This Is By Far the #1 Highest Paying Non-Executive Biotech Job in the U.S.
Biotech Bay
This Is By Far the #1 Highest Paying Non-Executive Biotech Job in the U.S.
April 17, 2017
 · 
6 min read
Genetown
10 Things Life Science Job Seekers Should Remove From Their Resume
April 7, 2017
 · 
1 min read
Biotech Beach
5 Career Options For PhDs Transitioning To A Career In The Real World
April 7, 2017
 · 
1 min read
Biotech Beach
9 Tips For Female Scientists
April 7, 2017
 · 
1 min read
Biotech Beach
How I Went From Refugee To Biotech CEO
April 7, 2017
 · 
1 min read
Biotech Bay
Scientist Gives Tips On How To Succeed In A Cancer Research Career
April 7, 2017
 · 
1 min read
From Biohacker to Organ Farmer, You Won’t Believe These Amazing 8 Biotech Jobs of the Future!
Biotech Bay
From Biohacker to Organ Farmer, You Won’t Believe These Amazing 8 Biotech Jobs of the Future!
April 6, 2017
 · 
6 min read
Top 10 Best Innovative Pharma Companies to Work For
Biotech Bay
Top 10 Best Innovative Pharma Companies to Work For
April 6, 2017
 · 
6 min read
MaxWell Biosciences CEO Faces Backlash After Openly Discriminating Against Men
Job Trends
Novogen Terminates Preclinical Program, Will Cut an Undisclosed Number of Jobs
April 6, 2017
 · 
2 min read
Load More
PRESS RELEASES
Drug Development
Recce Pharmaceuticals Doses Patients in Phase I/II Clinical Trial of RECCE® 327 for Diabetic Foot Infections
August 24, 2023
 · 
3 min read
Biotech Bay
Vaxxas Awarded US$3.67 million (AU$5.4 million) from global charitable foundation, Wellcome, for Human Clinical Study of Typhoid Vaccination using Needle-Free Vaccine Patch
August 23, 2023
 · 
8 min read
Ferronova and Purdue Research Foundation (PRF) Sign Licensing Agreement for Use of Fibroblast Activation Protein (FAP) Inhibitor in Radiotherapy
August 23, 2023
 · 
5 min read
Drug Development
Recce Pharmaceuticals Completes Stage 1 Data Analysis of Phase I/II Clinical Trial for the Treatment of Burn Wound Infections
August 23, 2023
 · 
5 min read
Biotech Bay
Alterity Therapeutics Granted New Composition of Matter Patent in Europe for Neurodegenerative Diseases including Parkinson’s and Alzheimer’s
August 23, 2023
 · 
6 min read
Drug Development
Bionomics Completes Last Patient Last Visit in the Phase 2b ATTUNE Study for Post-Traumatic Stress Disorder (PTSD) and Confirms Expected 2023 Milestones with its Lead Asset BNC210
August 23, 2023
 · 
5 min read
Business
Telix 2023 Half-Year Results: Revenue and Earnings Growth Marks Transition to a Sustainable Commercial-Stage Company
August 23, 2023
 · 
8 min read
Carina Biotech to Present Preclinical Data Evaluating LGR5-Targeted CAR-T Cell Therapy in Human Cancer Models at 8th CAR-TCR Summit
August 21, 2023
 · 
2 min read
Business
CSL Appoints Jeffrey Ball as First Chief Sustainability Officer
August 17, 2023
 · 
4 min read
Propanc Biopharma Targets Site of First-In-Human Study for PRP at the Peter Mac Cancer Center, Melbourne, Australia
August 15, 2023
 · 
5 min read
Biotech Bay
Alterity Therapeutics Receives a $4.74 million Research & Development Tax Incentive Refund
August 15, 2023
 · 
2 min read
BioMidwest
DurAVR™ THV Demonstrates Exceptional Results in Second Valve-in-Valve Case
August 14, 2023
 · 
5 min read
Immuron to present at the Military Health System Research Symposium
August 14, 2023
 · 
2 min read
Biotech Bay
US FDA DESIGNATES PYC’S LEAD AS A FAST TRACK DEVELOPMENT PROGRAM
August 11, 2023
 · 
3 min read
Drug Development
First Patient Dosed in Pivotal Phase III Study of TLX591-CDx (Illuccix®) for Prostate Cancer Imaging in Chinese Patients
August 10, 2023
 · 
7 min read
Clarity’s theranostic prostate cancer trial advances to highest dose level
August 10, 2023
 · 
8 min read
Recce Pharmaceuticals Provides Positive Update on Patients Treated with RECCE® 327 Under “Special Access Scheme”
August 10, 2023
 · 
7 min read
Genetic Technologies Limited Announces Updated Investor Presentation
August 9, 2023
 · 
2 min read
BioMidwest
Anteris Technologies Commences American Depository Receipt Program
August 9, 2023
 · 
3 min read
BioMidwest
Anteris Technologies Commences US Early Feasibility Study
August 9, 2023
 · 
4 min read
Load More